Skip to main content
Clinical Trials/ITMCTR2100004777
ITMCTR2100004777
Recruiting
Phase 1

A non-randomized controlled clinical trial on the effectiveness of xingnao-jianshen prescriptions in the treatment of ischemic stroke (experimental phlegm-heat and fu-organism)

Affiliated Hospital of Changchun University of Traditional Medicine0 sitesTBD
ConditionsIschemic stroke

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Ischemic stroke
Sponsor
Affiliated Hospital of Changchun University of Traditional Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Affiliated Hospital of Changchun University of Traditional Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\.Meet the diagnostic criteria of western medicine for ischemic stroke (acute phase);
  • 2\.Comply with the diagnostic criteria of TCM in the acute phase of ischemic stroke, the meridian (experimental phlegm\-heat fu\-organs);
  • 3\.The onset time is less than 14 days;
  • 4\.4\<\=NIHSS\<15 points;
  • 5\.Aged 40\-80 years;
  • 6\.The patient or the entrusted immediate family members sign the informed consent form.

Exclusion Criteria

  • 1\.Diagnose patients with other brain diseases based on head CT or MRI, such as cerebral hemorrhage, brain tumor, brain trauma, TIA;
  • 2\.Patients in a coma;
  • 3\.Patients need or have undergone thrombolysis or endovascular treatment;
  • 4\.People with allergies, allergic to test drugs or related ingredients;
  • 5\.Patients whose blood pressure is still less than 90/60mmHg or \>\=220mmHg/120mmHg after treatment;
  • 6\.Complicated with severe liver and kidney damage, and whose ALT, AST, Cr, and BUN levels are 1\.5 times higher than normal;
  • 7\.Accompanied by other complications and complications that affect drug evaluation, such as severe cardiac insufficiency, severe mental illness, depression and dementia after stroke, cerebral hemorrhage after cerebral infarction, etc.;
  • 8\.Past ischemic stroke mRS score \>\= 2 points;
  • 9\.Disabled patients (blindness, deafness, dumbness, intellectual disability, mental disability, etc.) stipulated by the law, and physical disability caused by other diseases affect the assessors of neurological impairment;
  • 10\.Patients with bleeding tendency or severe bleeding within 3 months;

Outcomes

Primary Outcomes

Not specified

Similar Trials